The dire need for proficient healthcare solution providers has made us look out for “The 20 Most Admired Healthcare Solution Providers 2018.” On our cover page we have Dr. Charudutt Apte, Chairman & Managing Director of Sahyadri Hospitals Ltd.

1. S O L U T I O N
PROVIDERS
2018
20
THE
MOST
ADMIRED
HEALTHCARE
Dr. Charudutt Apte
Chairman & MD
Editor’s Pick
Importance of
Data Security in
Healthcare
Sahyadri HospitalsSahyadri Hospitals
Shedding Light on Lives through Expertise and Commitment
Future Bots
Remote Healthcare -
A Modern Medical
Care
www.insightscare.com
Mar-Apr 2018

4. From the
Editor ith the inauguration of the Internet of Things, we can
Wsay that everything and everyone is connected. The
technological shift of this dimension is felt by every
division of the economy, every human being and every sector
including Healthcare. Internet of Healthy Things (IoHT) bridges
interoperability hurdles to transform radically the way in which
healthcare is delivered, driving high-grade results, increasing
efficiency and making healthcare affordable to all.
Wearable devices and home health monitoring devices assisting
patients is a common thing now. Whether data comes from
electrocardiograms or temperature monitors, tracking health
information is vital for all patients. Connected smart devices
facilitate real-time data reporting with the capability to transmit
critical data from a patient home to the hospital. It allows doctors
and hospital staff to have a real-time monitoring of patient’s
wellness. Increase in computing power is also a reason behind this
disruption. Our smartphones now hold more processing power than
entire rooms of early computers, and nowhere is that truer than in
the world of medical monitoring. The leaps and bounds that
technological progress has taken in the past few decades mean that
whereas once you’d have to go to a medical professional to get
information about.
This disruption made possible by IoHT is also creating an
opportunity to reduce the cost of healthcare delivery and allowing
healthcare to transform into value-based healthcare. Recently
published research shows that with remote patient monitoring for
the heart, asthma and diabetes patients will enable a total saving of
$200+ billion mainly due to the elimination of unnecessary and
redundant expenditures. The future is converging more on
interconnected devices, and all these methods will help to build
products that involve enough with patients to support them in
crafting health goals which are relevant to their life. Adopters of the
Internet of Things in Healthcare are rising steadily which delivers
very compelling messaging, sustain engagement and provide
powerful motivators to make health and wellness a part of our
everyday lives.
Sugandha Sharma
Modern Technology
Transcending the
Healthcare into
Value-based
Collaborative Care

5. Flourishing
Healthcare
Sector of India
n the terms of revenue and employment, Healthcare is one of the largest and vast sectors of India, and the
IHealthcare Industry comprises the Pharma, Biotech, Hospitals, Clinical Trials, Outsourcing, Medical Equipment,
Medical Devices, Health Insurance, and Medical Tourism. The Indian healthcare division is expanding at a brisk
pace due to its strengthening coverage, services and rising expenditure by public as well private players. India’s
competing authority lies in its large pool of well-trained medical specialists. India is also cost effective compared to
its peers in rest of the Asia and Western nations. The cost of surgery in India is around one-tenth of that in the US or
Western Europe.
Today, the Indian healthcare market is meriting US$ 100 billion and is expected to grow to US$ 280 billion by 2020
and a Compound Annual Growth Rate aka CAGR of 22.9 %. Healthcare services like hospitals, nursing shelters,
diagnostics centers and pharmaceuticals constitute 65% of the total healthcare market. There is still a significant
opportunity for enhancing healthcare considering that healthcare spending as a percentage of Gross Domestic Product
(GDP) is rising. Rural India in total accounts for over 70% of the total country population is set to emerge as a
potential demand source.
India is still in need of 600,000 to 700,000 additional beds over the next five to six years, indicative of an investment
opportunity of US$ 25-30 billion.The average investment size by private equity funds in healthcare chains has already
increased to US$ 20-30 million from US$ 5-15 million, as per PriceWaterHouseCoopers.
The dire need for proficient healthcare solution providers has made us look out for “The 20 Most Admired Healthcare
Solution Providers 2018.” On our cover page we have Dr. Charudutt Apte, Chairman & Managing Director of
Sahyadri Hospitals Ltd. since January, 2004. He is responsible for Sahyadri Hospital’s management and also oversees
the hospital’s activities while initiating unique targets and achieving accomplishments at various levels. Sahyadri
Group of Hospitals started its journey of possibilities towards making world-class healthcare available in Western
India. Sahyadri Hospitals is not just known for being the largest chain of hospitals in Maharashtra, but also for the
approach, where it brings in the best of experts in multiple specialities and the most advanced technologies to provide
a ray of hope—to give people the lifeline of possibilities, even in the most difficult cases.
So, flip through the amazing folios for insights on organizations striving hard to keep-up with the technological
disruption in the healthcare industry. Find out more about the trends in the industry through articles on ‘Health
Insights: Digital Health: A New Era for the Human Progress’ and ‘Tech-N-Trends: Hospital Wi-Fi: Making
Healthcare Smarter’ drafted by our in-house editors for this special issue.
Let’s get started then!

6. Future Bots
Remote Healthcare-
A Modern Medical Care
30
Sahyadri Hospitals
Shedding Light on Lives through
Expertise and Commitment
Inside Scoop
Engineered Babies:
Would you Prefer
Genetic Perfection?
38
Editor’s Pick
Importance of Data
Security in Healthcare
22
A r t i c l e s
08

7. CONTENTS
c x o
Expert’s Foresight
Molecular Genetic
Diagnostics: A Bird’s
Eye-View
Entrepreneur’s Outlook
Articial Intelligence
Marketing in Healthcare
Remodeling approach to care…
Executive Viewpoint
Exploring Healthcare
Marketing with
Articial Intelligence
CXO Insights
Pre-analytical Errors in
a Pathology Lab context
&Need for better
phlebotomy practices
Accurex
Biomedical
Saving Lives through
Quality Medical
Diagnostic Solutions
Adani
Pharmachem
Formulating &
Enhancing Future
through Innovative
& Quality APIs
Arlak
Biotech
Delivering Affordable
and Best Quality
PharmaProducts
Vovantis
Laboratories
Leading the
Pharmaceutical
Market while using
Effervescent Technology
26
34
18
42
20
24
32
40

8. Insights Success Media Tech LLC
555 Metro Place North, Suite 100,
Dublin, OH 43017, United States
Phone - (614)-602-1754
Email: info@insightscare.com
For Subscription: www.insightscare.com
Insights Success Media and Technology Pvt. Ltd.
Ofce No. 510, 513, 5th Floor, Rainbow Plaza, Shivar Chowk,
Pimple Saudagar, Pune, Maharashtra 411017
Phone - India: 020-69400110, 111, 112
Email: info@insightscare.com
For Subscription: www.insightscare.com
sales@insightscare.com
Corporate Ofces:
Mar-Apr, 2018
Database Management Stella Andrew
Technology Consultant David Stokes
Circulation Manager Robert, Tanaji
Research Analyst Chidiebere Moses
Editor-in-Chief Pooja M. Bansal
Executive Editor Shane Gomez
Art & Design Director Amol Kamble
Associate Designer Rahul Kavanekar
Visualiser David King
Senior Sales Manager Matt Ryder
Managing Editor Sugandha Sharma
BelinArt & Picture Editor Paul
Co-designer Sapana, Shweta
KhannaJayant
Justin SmithBusiness Development Manager
Sales Executives
Sophia Young, Paul Cooper, Grifn Willams
SME-SMO Executives
Prashant Chauhan, Uma Dhenge
Digital Marketing Manager Marry D’Souza
Technical Specialist Amar, Vivek, Pratiksha
Technical Head Swapnil Patil
Copyright © 2018 Insights Success, All rights reserved. The content and images used in this magazine should not be reproduced or transmitted in
any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission from Insights Success.
Reprint rights remain solely with Insights Success.

10. Dr. Charudutt Apte
Chairman & MD

11. Shedding Light on Lives through
Expertise and Commitment
COVER STORY

12. COVER STORY

13. We bring in the best of
experts in multiple
specialities and the
most advanced
technologies to provide
a ray of hope…to give
people the lifeline of
possibilities—even in the
most difficult cases
‘‘
‘‘

14. We’re the flag bearers of
hope when most
hospitals say ‘No’ and
we handle those cases
successfully
‘‘
‘‘

15. Healthcare
www.usa.philips.com

16. Address :
Country :City : State : Zip :
Global Subscription
Date :
Check should be drawn in favour of : INSIGHTS SUCCESS MEDIA TECH LLC
Yes I would like to subscribe to Insights Care Magazine.
Name :
1 Year.......... $250.00(12 Issues) .... 6 Months ..... (06 Issues) ..... $130.00
3 Months ... (03 Issues) .... $70.00 1 Month ...... (01 Issue) ..... $25.00
Telephone :
Email :
Insights Success Media Tech LLC
555 Metro Place North, Suite 100,
Dublin, OH 43017, United States
Phone - (614)-602-1754,(302)-319-9947
Email: info@insightscare.com
For Subscription : www.insightscare.com
CORPORATE OFFICE
SUBSCRIBE
TODAY
Never Miss an Issue

17. Company Name Management Brief
Accurex Biomedical
Pvt. Ltd.
accurex.net
Abhinav Thakur
Managing Director
Accurex Biomedical Pvt. Ltd. is an Indian manufacturer
and marketer, which provide accurate and quality
solutions in the diagnostic industry.
Adani Pharmachem
Private Limited
adanipharma.com
Rushabh Adani
Managing Director
Adani Pharmachem Private Limited is a trusted
manufacturer, exporter, wholesaler and supplier of
API’s & Fine Chemicals.
Aravind Eye
Care System
aravind.org
Dr. Govindappa
Venkataswamy,
Founder Chairman
Aravind Eye Hospitals is a hospital chain in India, has treated
nearly 32 million patients and performed 4 million surgeries,
the majority of them being cheap or free making it the
world’s largest and most productive eye-care service group.
Arlak Biotech Pvt. Ltd.
arlakbiotech.com
Umesh Kalra
Founder & CEO
Arlak Biotech is a leading Pharma Company, which offer
an extensive variety of PCD Pharmaceutical products to
healthcare industry at the most affordable cost.
Bharat Serum and
Vaccines Limited
bharatserums.com
Syd Daftary
Business Development
Bharat Serums and Vaccines is one of the fastest growing
biopharmaceutical cmpanies in India.
Cachet Pharmaceuticals
cachetindia.com
Cachet is one of the India’s leading pharmaceutical company,
engaged in manufacturing and marketing of a wide range of
pharmaceutical formulations and nutraceuticals to meet the
demands of domestic and international market.
Chandan Healthcare Ltd.
chandan.co.in
Dr. Amar Singh
Founder and chairman
Chandan Health Centres, started by the Chandan group,
are providing diagnostic services as well as have retail
outlets for medicines in 9 states with 80 centres.
Ciron Drugs &
Pharmaceuticals
cironpharma.com
Samir Ratanshi Shah
Director
Ciron Group of Companies has been involved in
developing a growing portfolio of best-in-class
pharmaceutical formulations in the healthcare arena.
Enaltec Labs Pvt. Ltd.
enaltec.com
Hammad Shah
CEO
Enaltec Labs is a fast emerging API manufacturer & supplier
set up by a group of young professionals with the specific
objective of providing the critical India advantage to generic
formulators across the world.
F. D. C. Ltd.
fdcindia.com
Mayank Tikkha
Head Sales
Force Excellence
FDC carries forward the flaming spirit of it's first dream, achieving
accreditations from the US-FDA, UK-MHRA, MCC-RSA, and the
UAE, to cite a few. FDC is a forerunner in the manufacture of ORS and
Ophthalmics, by setting up, globally approved, multi-location
manufacturing facilities for APIs and Finished Dosage Forms.
Shashi Shekhar Kumar
VP International Business

18. Company Name Management Brief
Healthkind Labs Pvt. Ltd.
healthkindlabs.com
Rohtas Sharma
MD
Healthkind Labs Pvt. Ltd. Is an ISO 9001:2008 certified
company, prominent supplier, trader & distributor of
premium quality Pharmaceutical Medicines. offering Pharma
Franchise and Pharma PCD.
KMC SPECIALITY
HOSPITAL
kmcspecialityhospital.in
Rushabh Adani
Managing Director
KMC Speciality Hospital is the new age family hospital group,
with a strong culture of personalized patient care, and a
reputation of having established centers of excellence across all
medical specialties and allied health services and be regarded as
the most valued service provider with national acclaim.
Megafine Pharma
megafine.in
Ashok K. Jhaveri
Director
Megafine is a privately owned and professionally managed
enterprise, provides innovative & integrated API solutions with
it's decades of experience and skill in the development of novel
chemical processes catering to the global drug discovery and
generic companies.
Sahyadri Hospitals Ltd.
Dr. Charudutt Apte
sahyadrihospital.com
Dr. Charudutt Apte
Chairman &
Managing Director
Sahyadri Hospitals, the largest chain of hospitals in
Maharashtra, is a hub of quaternary care and a leading referral
centre for multiple specialities such as Neurosurgeries,
Haematology, Cardiac Sciences and Organ Transplants.
Sance Laboratories
sancepharma.com
Manoj Joseph
Managing Director
Sance Laboratories is expert in manufactures and supply
cephalosporin antibiotics in dosage forms like DRY POWDER
FOR INJECTIONS, TABLETS, CAPSULES and DRY
SYRUPS for various countries around the globe.
Shalina Laboratories
shalina.com
Shalina Healthcare is a market leader in making quality
healthcare products affordable and available across Africa.
South India Surgical
Co Limited
sisco.in
Rohit Bajaj
Director
South India Surgical Company is one of the pioneer
companies in the Surgical Industry in India.
SRS Pharmaceuticals
Pvt Ltd
srslife.com
José Miguel Retamal
Chief BusinessOficer
SRS Life Sciences is redefines the future of
pharmaceutical industry by changing the way consumers
experience medicines.
Supriya Lifescience Ltd.
supriyalifescience.com
Satish Wagh
Founder
Supriya Lifescience takes pride in setting the Gold Standard
for Products, Processes, and Systems, having four State-of-
the-art plants, a slew of Awards and Registrations in 35
countries speak volumes of our global stature and success.
Vovantis Laboratories
vovantis.com
Mohal Sarabhai
CEO & Director
Vovantis Laboratories is the global supplier of effervescent range of
products offering basic products like tablets or packets of Vitamin C,
Aspirin, multi vitamins and acetaminophen along with several
combinations for cold/cough remedies as well as prescription medicines
like Tramadol and Sildenafil in effervescent forms.
Shashi Shekhar Kumar
VP International Business

19. Care instructions distributed
via mobile devices shared by
Care Teams
Mobilize Care Actions
Family, friends and
Professional community care
providers
Care Teams
Access to lifestyle
products/services to keep
people in their homes
Lifestyle Support
Community Care Collaboration (C3) Model
Because together, we’re better. Our C3 model – Community Care
Collaboration – supports care programs that require high levels of
collaboration between interdisciplinary care providers, patients, and family
caregivers. Our goal is your goal: to keep patients independent, living
comfortably in their homes.
Care3.co

20. · Is AI for real? Is it the disruptive technology which Healthcare is looking for?
· Are jobs going to be lost? Are we heading towards completely changed marketing approach in Healthcare?
· What disruptions should healthcare executives prepare themselves for now?
· How will the healthcare industry operate differently in 5 or 10 years into the future?
We all are seeking the answers to above questions and discovering the answers every day of those. Artificial
intelligence (AI) has truly moved from concept to reality in the healthcare and pharmaceutical industry. AI has
simplified data processing for many companies, to pour through mountains of scientific data to speed and improve the
drug discovery process. AI has made inroads in areas as diverse as regulatory/compliance, clinical trials,
manufacturing, and supply chain.
This brings us to the most pertinent aspects of pharma marketing.
• What are the main challenges for pharma companies to bring on and integrate AI talent and tech?
• How can they be better prepared for a data-fueled, machine learning future?
AI can transform Pharma marketing
Artificial intelligence and machine learning based analytics are superior for marketing, and this is due to aggregator
impact of knowledge processed by various channels. As the number of information channels increases dramatically due
to technology adoption by various stake holders, like patients, physicians, pharmacists, medical representative,
publications; the complexity of these channels, the fast pace of change in our market environment itself and the
complexity of the decisions, it is not possible without the help of AI to make any sense of these interconnected but
complex data.
Therefore, using AI powered analytics can sophisticatedly deliver accurate marketing decisions. Artificial intelligence
is perfect for Pharma marketing departments because it can undertake large volumes of interconnected and complex
judgmental decisions by sieving through a multiple of seemingly unrelated datasets, and this with a high degree of
accuracy. The challenge in these multichannel, digital data remains is providing actionable insights are crucial.
AI guided Sales Rep
In this highly competitive world of generic brands, coupled with reducing in clinic time, sales teams are struggling and
must find new and different ways to engage with physicians. Sales reps are expected to do more with less; the
implementation of technology solutions has become increasingly critical.
AI will help simplify the pharmaceutical sales teams’ ability to process large volumes of doctor and patient data and
derive from that data accurate and consistent findings resulting in improved patient and doctor outcomes, as well as
share real-world clinical outcomes. So, it may be possible soon for sales rep before entering the clinic know, about the
Healthcare Marketing
Exploring
Artificial Intelligence
with
18 Mar-Apr 2018/

21. physicians preferred brands,
indications he is prescribing and create
customized information as per
physician’s specialty and prescription
pattern. In real time churn out analytical
data from millions of published data, to cater
to any query raised. This will help reps with
guided selling tools so that they can give a more
targeted, impactful message. When the message
and content is more timely and relevant, detail
time increases. When detail time increases, sales
increase.
Using AI to automate tasks will free up sales rep
time, for instance, technology can help by
automatically logging calls with physicians, nurses,
pharmacists and other key customers into customer
relationship management (CRM) systems. Automated
order and report generation can not only free his time but
also predict trends for accurate forecast of sales.
Also, for marketing it would be easy to share best practices adopted by
successful sales rep during their engagement with physicians, so that it can be cascaded in the entire chain,
and greatly improving their chances for a successful outcome. In other words, AI can become a sales trainer
and mentor that are always by the sales rep’s side, in real time and not during yearly reviews.
Challenges in adoption
The healthcare and pharmaceutical industry has been a late adopter of most innovative technologies, even
though they do have huge R&D budgets at their disposal. Each company generates terabytes of data and
keeps it hidden behind a firewall. Partly, this is due to strict regulatory and compliance standards and partly
due to an extremely competitive environment in which these companies operate. Management often doesn’t
see sufficient value in something that requires such a major investment.
The biggest challenge is talent. AI experts rarely have an expertise in life science, there’s a big gap in how
biology experts and computational experts think. Consequently, there is a great competition for the few
experts who can bridge both domains. Companies will have to build this very important resource, and this is
going to be major challenges for them. We really needs interdisciplinary innovation and collaboration to
apply AI to solve meaningful problems in life sciences.
Conclusion
AI is increasingly proving to be of great relevance, is an opportunity and companies who can harness it
will gain the advantage. The scope to effectively utilize the full potential is huge and could be easy
as it is easy now to capture a massive volume of pharma related high quality raw data, for
tailor-made innovative analysis, with the help of AI to create actionable intelligence.
Executive Viewpoint
Dr. Mamta Jain
MD
Medwiz Healthcare
Communications
Mar-Apr 2018 19/

22. AccurexAccurex
Biomedical:Biomedical:
Accurex
Biomedical:
Saving Lives through
Quality Medical
Diagnostic Solutions
Managing Director
Abhinav Thakur
Diagnostics in an important component of improved
value chain in the healthcare sector. The medical
diagnostic industry has undergone significant
transformation, driven by the innovation of medical devices
and the tremendous growth in the integration of Internet of
Things (IoT). Medical diagnostic devices are now being
developed with wearable technology, connectivity, and
personalized healthcare data in mind in order to provide
essential information along the healthcare continuum.
Meanwhile, factors such as aging populations and the
increase in chronic diseases are also driving the growth of
the global medical diagnostic industry.
The medical diagnostic industry is expected to play an
increasingly important role in the next several years, as the
global healthcare industry agenda is likely to shift from
treatment to prediction, prevention and diagnosis. The focus
on early detection and prevention of medical conditions will
increase globally, while scientific innovations such as
molecular and genetic testing will further boost the
evolution of medical diagnostics towards more personalized
treatment.
Apprehending this, Accurex Biomedical was founded in
India with an aim to provide indigenous manufacturing of
diagnostic reagents. Accurex is the first company to
manufacture enzymatic clinical chemistry reagents in India.
Established in 1984,
Accurex provides medical
diagnostic solutions to pathology labs.
They manufacture diagnostic reagents and trade in
diagnostic instruments thus providing a complete solution
to pathology labs.
Today, Acuurex is one of the top three manufacturers of
quality clinical chemistry reagents and urine analysis test
strips with over 30 years of expertise in this area. Accurex
is composed of two words, ACCU and REX. “ACCU”
refers to the word accurate and its definition by the Oxford
dictionary portrays the essence of their existence. “REX”, a
Latin word for ‘king’, speaks of their authoritative influence
in the diagnostic industry.
Guided by clear vision and driven by innovation, Accurex
has gained considerable expertise in manufacturing and
marketing of In-vitro Diagnostic reagents. It has built a
reputation of quality products, a strong financial base and
dynamic marketing. Headquartered in Mumbai, the
commercial capital of India, Accurex has branch offices in
metros like New Delhi & Kolkata ensures a rapid customer
response time and optimal market reach.
20 Mar-Apr 2018/

23. Customer
delight is at
the forefront
in all our
business
strategies
‘‘
‘‘
An Erudite Leader
Abhinav Thakur,
Managing Director,
Accurex Biomedical, is a
graduate of world renowned
University Of California-Davis. He has
completed his PGDM from NMIMS University,
Mumbai. He has been Managing Director at ACCUREX for
more than 12 years. He is responsible for establishing goals
and developing strategies, raising funds, investing in
resources and conducting operations at ACCUREX.
Previously he has worked with SODHEXO, University
Police and California Diabetes Prevention Program in
California, U.S.A.
He is also the Jt. Coordinator- Mumbai of Association of
India Medical Devices Industry (AIMED) and treasurer for
the Association for Diagnostic Manufacturers of India
(ADMI).
“At Accurex, we have committed ourselves to a shared set
of values that are binding on all employees,” says Abhinav.
Everything they do is based on their corporate values:
Honesty, Perseverance, Helpfulness, Creativity,
Advancement and Prosperity. “These values give us
orientation, and they determine our business relationships
and of course how we cooperate within the company,”
added Abhinav.
Exceptional Services and Solutions
Accurex Biomedical Pvt. Ltd. is an Indian manufacturer
and marketer which provide accurate and quality solutions
in the diagnostic industry. They have been in this business
for over 30 years and are currently one of the top 3 Indian
companies in the field of Clinical chemistry, and are known
for their high quality products.
Accurex is an ISO certified company with state-of- the-art,
FDA approved Manufacturing, Quality Assurance and R&D
facilities meeting the stringent requirements of Good
Manufacturing Practices assuring superior quality.
Independent Quality Assurance department establishes
policies and procedures designed to monitor all aspects of
the manufacturing process like inspection of raw materials
and packaging materials, on-line production checks and
finally, finished product release testing.
Accurex is now the only company that provides a
Performance Data Sheet along with every product pack
with the evaluation data of each of their products with six
Internationally Recognized control sera.
Moreover, the company has a wide array of products
ranging from Clinical Chemistry reagents, Serology test
kits, Urinalysis analyzer and strips, blood glucometer, Semi
& Fully Automated Clinical Chemistry Analyzers,
Electrolyte Analyzers and Hematology analyzer.
Accurex has dedicated personnel committed to prompt
product delivery and complete customer satisfaction along
with a team of well-trained engineers for after sales services
that add up to an excellent sales and service network.
“Customer delight is at the forefront in all our business
strategies,” asserts Abhinav.
Upcoming Endeavors
“The brand equity built over the past three decades is the
best part of Accurex. We are going to leverage it by
launching new products,” says Abhinav. With quality as
their minimum requirement, Accurex aims to provide the
healthcare industry with the best diagnostic tests and
biomarkers to provide accurate, rapid and efficient
treatment. The aim of Accurex is to research, develop,
manufacture and market ‘value-added’ diagnostic products.
Mar-Apr 2018 21/

24. C
urrently, the healthcare industry is adopting new
technologies rapidly. Predominantly, the
Information Technology, which is used to assist
both doctors and patients alike, and to improve the delivery
of healthcare services. The most important section of a
hospital information system today is the Electronic Health
Record (EHR), where patient information is stored.
Furthermore, a countless number of applications are used
by the hospital staff to monitor the medical facility’s
performance in terms of financial efficiency and treatment
success rates. In addition to this, Government and federal
organizations also use IT solutions to check the quality and
safety of healthcare organization. Moreover, patients use
various health monitoring apps and devices to monitor their
vitals and to communicate with doctors through mobile and
wireless technologies.
Now-a-days as computers have become an essential part of
our daily lives, it is increasingly important that data security
is also placed front and center on our list of priorities.
Mainly in the healthcare industry, where thoughts are often
focused on saving someone’s life and rightly so, but
securing access to interfaces and computer systems that
store private data like medical records is also an essential
factor to consider. Data security is a corresponding action
between controlling access to information while allowing
free and easy access to those who need that information.
Although extensive digitization of information in the
healthcare sector has improved the healthcare services
making them fast and efficient, the information security risk
is also very real. In 2016, information security breaches in
the healthcare industry affected more than 27 million
patients.
Given the sensitive nature of
healthcare data it is vital for
healthcare providers to have a
robust and reliable information
security service in place. The
strategies should not only react
and protect the healthcare data,
but also predict and prevent any
assaults launched by cyber
criminals. In the recent years,
cyber criminals are interested in
the electronic medical records as
the black market rate for this
kind of information is much
higher than the credit card
numbers or bank account passwords.
This trend might be surprising, but the reasons are quite
obvious. Altogether, the data in the electronic medical
records contains: patients’ names, their dates of birth,
addresses, phone numbers, places of work and positions,
IDs, card numbers, medical and social insurance. Stealing
of such information can lead to a complete identity theft,
rather than just a one-time bank hack.
Another important reason is weak protection of patients'
data in medical institutions. Financial institutions like banks
have already created a strong system of data protection. The
two-factor authentication has become a universal standard
for banks. The bank allows its client access to the
information only after entering the One-Time Password.
But on the contrary, in public health associations such
systems have not being implemented in a long time and
22 Mar-Apr 2018/

25. thus they become an easy victim for the cyber criminals.
Below are some of Healthcare data security tips that can be
implemented to maintain a secure data environment:
Despite all the vulnerabilities healthcare data security
encounters in the age of technology, there are enough ways
to reduce these risks. Similar to any other type of
organization, medical facilities needs data protection from
dangers like; targeted attacks and hacking, virus infiltration,
employee actions committed due to illiteracy or with a
purpose to steal medical records.
The first two are generally eliminated by cyber security
experts. To prevent the human factor, in addition to the
administrative work with the staff, the medical institutions
need to adopt a reliable means of strong user authentication
when gaining access to the electronic medical records and
patients’ data.
Since the owners of the insurances don’t get the billing
information immediately, it is difficult to spot that the
medical records storage has been hacked. The banks usually
immediately inform their customers about any actions on
their accounts via text messages. Thus, the person, if
necessary, may report on a particular suspicious transaction.
Moreover, often the bank clients need to confirm their
identity to make a transaction. If such means of user
authentication were used in medical facilities, many
healthcare data frauds could have been avoided.
The two-factor authentication with one-time passwords has
become the standard for a great number of different digital
companies. Hardware and software OTP tokens, which
generate the one-time passwords, are often used to increase
the data protection level. These tokens do not need Internet
connection, and thus help to avoid OTP passwords
interception. Two-factor authentication has proven its
reliability a long ago and thus, it may be useful for the
healthcare data security as well.
Conclusively the IT solutions in healthcare industry must be
developed and used in agreement to all the standards to
avoid risks and provide maximum data security.
Implementing proper data protection strategies and
solutions will enable medical facilities to fulfill the
monitoring and reporting regulations and share data
securely.
Editor’s Pick
Mar-Apr 2018 23/

26. AdaniAdani
Pharmachem:Pharmachem:
Adani
Pharmachem:
Formulating & Enhancing
Future through Innovative
& Quality APIs
Managing Director
Mr. Rushabh Adani
Established in the year 1981, Adani Pharmachem, is
engaged in manufacturing, exporting, wholesaling
& supplying an array of APIs (Active
Pharmaceutical Ingredients) & Fine Chemicals. This range
of products is formulated using factory-tested chemicals,
which are obtained from a trustworthy vendor base of the
industry. The company has invested resources to find this
vendor base. Apart from this, Adani Pharmachem uses latest
technology to formulate the chemicals, with strict
adherence to set norms and standard of the industry.
Therefore, the chemicals of Adani Pharmachem are widely
appreciated for accurate composition, longer shelf life, high
effectiveness and best purity.
The Dynamic Young Leader
Mr. Rushabh Adani, Managing Director of Adani
Pharmachem is a B.B.A. graduated from Christ College,
Rajkot (Sau. University). He has over 16 years of
experience in Manufacturing & Exporting of APIs and Fine
Chemicals
Mr. Rushabh joined Adani Pharmachem Pvt. Ltd. in Year
2000 with vision to start export of their products within
span of 2 years of his joining; Company started exporting
their products in 10 countries with almost 55% jump in
sales from preceding years. From there onwards there was
no looking back and year on year company sales was
increasing and company gain rapid name and growth in
International Market. In
spite of not having technical
degree, he was very much successful in
marketing pharmaceutical products having gained
knowledge from technical staff and industry personnel.
Today, the company manufactures more than 30 odd
products in various categories and Exports their products in
more than 35 countries with 75% of sales in International
Market. He has gained experience and technical knowledge
under the guidance of his father, Late Shri Haresh Adani,
Founder of the company.
The Pillar of Adani Pharmachem
Adani Pharmachem is supported by an expert team of
professionals and it works hard to deliver the best quality
products to the customers. Their team members comprises
Q.C. Chemists, Q.A. Executives, Plant supervisors,
Manufacturing Chemists, Marketing & sales executives,
Export officers, administrative professionals and
warehousing & packing professionals. All the members of
Adani Pharmachem’s team works in unity to achieve the
goals of the organization.
“Apart from our team, we are supported by a state-of-the-
art infrastructure which is spread over a large area of
24 Mar-Apr 2018/

27. Enhancing
Lives since
1981
‘‘ ‘‘ operation
. We have
installed all
the requisite
machinery in our
formulation unit to
fulfill bulk of orders
within committed period of
time. Our research &
development unit tries to innovate
cost-effective and new manufacturing
processes without hampering the quality of the
chemicals. This unit also tries to develop the new products.
We export in Africa, Asia & American Countries & Indian
Sub-continent,” asserts Rushabh.
Adani Pharmachem’s Say on the Current Industry
Scenario
Adani Pharma believes that the pharma market is becoming
highly competitive and also dominated by low price means
competitive pricing. Now a day’s lots of new drugs are
being introduced and in this world so existing old drugs are
facing problem of lower demand and product life cycle is
decreasing. Also stringent rules and regulation in industry is
reason for slow growth rate. In this era one has to provide
best quality of product at highly competitive price Industry
is facing lot of competition from China. Due to drug price
control on many finished formulation market for Bulk drugs
is very competitive these days.
The Company’s Success
Adani Pharmachem attributes its success to the longer
visionary promoter of the company late Shree Haresh
Adani. They say that it is his training that have made them
capable and attain this position. It’s his expertise, which has
helped the company to reach at this level. Moreover, efforts
of their employee and workers also played vital role in
company’s success.
Overcoming Challenges
Challenges are the part of life ups and downs may come but
what counts is how we face them and overcome them. At
Adani Pharmachem also faced many challenges in the
period of 34 years.
Sometime, challenges might be quality, price finance
customer specific need, but the company strives to
overcome all because of dedication of their dedicated team
and top management efforts.
Also customer audits and certification processes are
challenging and Adani Pharmachem tries to resolve it with
expertise help. Also, these day environmental issues are the
bigger challenges, but company has overcome them with
professional help and latest environmental protection
equipment.
Maintaining Long Term Relationship with Clients
Customers are king and key point of success is having
strong customer base.
In order to build a strong customer base providing quality
product on the regular basis is key point. Secondly, along
with quality, timely delivery of the goods with competitive
prices too are vital in developing some personal relationship
with friendly behavior and having their odds they trying to
solve their problems prompt action on any issue contributes
to successful customer base.
Future Perspective of Adani Pharmachem
Hard work and Innovation should be the DNA of any
industry.
As many new drugs are introduced APIs industry is
growing too, so market and demand will increase. Customer
will get innovative new product at competitive rate, best
quality, services and availability on timely basis. Adani
Pharmachem’s teamwork, dedication of each and every
member of the unit and punctuality is the best part and with
the help of the company’s R&D team their knowledge
Adani Pharmachem is soon going to introduce new product
with the company growing at pace of 20 %. The company is
also striving to increase manufacturing capacity to meet
increasing demand.
Mar-Apr 2018 25/

28. Molecular
Genetic
Diagnostics:
A Bird’s Eye-View
G
enetic testing, especially molecular genetic
diagnostics, has evolved rapidly since the advent
of the twenty-first century, thereby prompting a
corresponding evolution in patient management and the
healthcare industry. Recent advances in molecular biology
research have opened a portal to plenty of phenomenon that
were previously heard of only in science fiction, such as
gene editing, personalized medicine, and even designer
babies. A literal interpretation of the term ‘genetic testing’
would refer to the analysis of changes (known as mutations)
in the hereditary material or DNA (deoxyribonucleic acid)
of an individual or group of individuals to confirm or
predict health-related outcomes. A genome refers to the
complete set of genes that an individual possesses and the
study of this is referred to as genomics. The concepts of
genetic and genomic testing are relatively novel for the
larger population and present multiple challenges for
everyone involved, including the clinician, patient, and
even the scientists developing the tests.
Genetic testing is available in a plethora of flavors, so to
speak, ranging from the genuine, actionable and relevant to
poorly regulated, ambiguous fluff. Accurate molecular
diagnosis can impact patient treatment by comprehensively
identifying the disease condition and providing the clinician
with treatment modalities. In addition, one can also
ascertain if a family member carries a risk of developing the
same condition. Therefore, it is of primary importance to
uphold impeccable laboratory quality standards to minimize
the scope of error.
In an effort to remedy this, a comprehensive team that
includes diverse specialists such as molecular biologists,
medical geneticists, clinicians, bioinformaticians,
histopathologists, and genetic and psychological
counsellors is required to overcome the scientific, technical,
social, and psychological implications of a molecular
genetic test. Their expertise extends to choosing the right
technique and avoiding unnecessary testing with the aim of
minimizing the financial and psychological burden on the
patients.
Countless applications of molecular and cellular biology
have permeated across various fields ranging from
agriculture to healthcare. For example, modern oncology
relies heavily on molecular testing for disease management
decisions. Successive testing for mutations in family
members of the patient has proven to be cost-effective with
long-term benefits. Disease predisposition and prophylactic
measures are based on such genetic evaluations.
The prevalence of conditions such as muscular dystrophy,
dysmorphism, intellectual disability, and disorders of sexual
differentiation are commonly observed in young children.
26 Mar-Apr 2018/

29. This has prompted pediatricians to use molecular tests to
augment their clinical acumen. Reproductive and maternal
health too has been revolutionized owing to developments
in molecular biology. This is critical for family planning
and its possible implications in cases of hereditary disease
and consanguineous marriage as most reproductive
decisions are seriously impacted with this knowledge.
Genetic testing is proving to be invaluable in the diagnosis
of critical infections such as sepsis and transplant-
associated infections as timely intervention is of paramount
importance in such cases and genetic tests have a very short
turnaround time compared to classical microbiological tests
such as urine or blood cultures.
Pharmacogenomics, better known as personalized
medicine, enables doctors to utilize the genetic profile of an
individual to tailor a therapy, and its dosage, that would
elicit the maximum response with minimal adverse effects.
This helps improve the prognosis in cases of cancers, single
gene disorders, neurometabolic disorders, and
hematological disorders. To maximize on this wealth of
information, it is essential to establish certain parameters
that include correct interpretation and communication, right
bioinformatic support, non-directive genetic counseling and
open access to population databases for comparison.
Every developing technology, however, has its own caveats
and pitfalls, some of which are unnecessary testing,
improper validation of tests and limited access to
population databases. In addition, the ethical complexities
of access to such information need to be reviewed as life-
altering decisions may be based on the findings of the test.
It is imperative to maintain patient confidentiality and
results must always be conveyed by authorized and trained
personnel owing to the social stigma attached to such tests
as discrimination by employers, family members and
societal pressure lead to disfavoring outcomes. Establishing
and following guidelines to avoid unnecessary screening
and testing should be mandatory.
The impact of genomics is far-reaching and tapping into
new horizons. Data for the first human genome was
assimilated over a span of thirteen years through
cumbersome research. Since then, however, exponential
leaps in technology have shortened the time and monetary
investment required for whole genome sequencing (WGS),
thereby making personalized medicine a reality. Artificial
Intelligence (AI) will bridge the gap in accessing global
databases for data analysis and reduce human dependency
to a large extent. Awareness and education, however, are
required for the population and the clinicians to benefit
from the recent breakthroughs of modern molecular
science. Genomics is at a nascent stage and caution through
good governance is required to ensure that it evolves
rapidly to make concepts like gene editing a reality in our
lifetime.
Ms. Kavita Khatod
MBBS, MS (Molecular and Cell Biology),
Certified Medical Geneticist
Head, Technical Marketing & Genetic
Counselor
GenePath Dx
Expert’s Foresight
Mar-Apr 2018 27/

30. At we’re driven by aHorizon,
clear purpose; to improve
Patients’ Lives.
w w w . h o r i z o n p h a r m a . c o m

31. Helping all people
live healthy lives
w w w. b d . co m

32. Remote Healthcare
Remote Healthcare’ - one of the
most finesse concepts that
have evolved in the medical
sector. In today’s modern society,
everything is getting more modern
including medicine and healthcare
industry and that’s mainly because of
the evolving technologies. The way
Remote Healthcare is taking care by
gathering and transferring the health-
related data, it is gaining popularity.
Nowadays, due to advancement in the
mobility and sensor technology, remote
healthcare has become a highly
attractive concept for everyone.
Technology is becoming more
pervasive. It is observed during a
survey, that top pharma companies are
having 63% more unique apps and the
number of healthcare app has more
than doubled in two and a half years.
The fact that nearly about 75% people
go online for health information, it
becomes quite clear that Remote
Healthcare has been proved to be
extremely beneficial for patients.
Patient’s expectation is to get better
treatment with satisfaction and Remote
Healthcare technology providing both
high satisfaction and better treatment
for patients.
The important key factors which are
responsible for increasing the use of
healthcare apps are trustworthy,
accuracy of data, ease of use,
simplicity, and design, and a guarantee
of data security.
The benefits of remote healthcare for
providers i.e., for doctors and for
medical cares are that- they believe the
technology can improve outcomes of
health, minimizes avoidable service
use, focuses on prevention, and
promote patient independence. Real-
time facts like paperwork time have
lowered nearly about 60% because the
hospital admissions itself has
decreased by 35%, the patient’s face
time i.e. the time taken by the doctors
and patients to interact with each other,
has increased by 29% this means they
can probably spend more time with the
patients, these are the evidence of
remote healthcare technology are
benefits for providers too.
Technology has power to improve
access to healthcare services,
especially for people with mobility
problems, whereas opportunities in
using mobile technology have also
improved in this endeavor. The
population of smartphones and tablets
users is growing fast irrespective of
any age group. Even the older
generation is finding it fruitful due to
the presence of heath support apps.
People are getting attracted towards
healthcare apps because of the notable
development in the field. Additionally,
smartphones are incorporating a
growing range of sensors which
monitors changes in physiology.
Remote healthcare includes one of the
technologies called Remote patient
monitoring (RPM). This RPM has an
ability to remotely monitor patients is
helping doctors to achieve great
coordinated care. It is also called
Homecare Telehealth, a type of
ambulatory healthcare service that
allows a patient to use a mobile
medical device to perform a routine
test and send the test data to a
healthcare professional in real-time.
Today we have a large number of
availability of remote healthcare
services using video-conferencing
equipment, mobile services, internet
access, remote monitoring devices and
other tools. We can exchange real-time
updates with doctors via smartphone,
which is recorded for the further
analysis.
Another one of the technologies called
Microelectronic Technology
(MEMS), which is basically focused
on the ways to implant those
microscopic devices on the body. With
the help of this technology, one can
have access and connection to
smartphones, through which exchange
of data can take place anywhere in the
world.
The real excitement for doctors is – ‘To
be in two places at the same time’.
And, that’s why doctors are able to
keep track of more than one patient at a
time and treat them in parallel.
Basically, the devices which are given
to patients will instantly measure vital
signs such as blood pressure, heart rate,
and sugar level etc.
‘
30 Mar-Apr 2018/

33. Reasons Worth Investing in Remote Healthcare
Medical cares are increasingly implementing Remote
Healthcare. Following are some reasons for the increasing
interest in the Remote Healthcare.
Time-saving
Remote Healthcare technology minimizes the
hospitalization time in order to support the patients in a
given time period. So, patients do not need to wait for
admission, and instead of joining waiting list or bed, they
can receive treatment in their own home; and this can also
help in reducing stress.
Relief for Staff
Medical center staff can now catch a breath through remote
healthcare technology. All the monitored patients don’t lose
the sense of safety because they can quickly contact a
specialist whenever needed.
Control over treatment
The advanced solutions allow remote monitoring,
observation of trends, and change dynamics in patient’s
vital parameters. This advanced treatment increases the
percentage of patients due to the improved treatment
efficiency.
Improved Treatment Efficiency
One of the reasons is long-term patients monitoring with
improved treatment. This results in a continuous
measurement of selected parameters of the patient. The
response time is very short in the remote healthcare
technology, so the risk is lowered by using these services.
Greater prestige for the Center
Launching of innovative services based on new
technologies is positively affecting the medical centers’
image. These incredible solutions assure flexibility and
thereby improve quality of a patient’s life.
Cost Optimization
Applications of remote healthcare are optimal solutions for
the cost. It owes services with telemedical functions and
advanced online communication which is neither bound to a
single location. Such technology includes online medical
conferences that allow residents small of towns where
direct access to doctors is often limited, they
can get benefits from specialist anywhere in the world.
Ultimately, Remote Healthcare provides a safety buffer
around the patient. Patients are supported remotely by the
healthcare professionals, who can access their well-being at
the tap of their fingertips. As Remote Healthcare plays an
important role in improving the lives of patients, it is a
proper application of wireless technology, which has a
potential to increase effectiveness, decrease costs and
generally improve the quality of healthcare.
Future Bots
Mar-Apr 2018 31/

34. ArlakArlak
Biotech:Biotech:
Arlak
Biotech:
Delivering Affordable
and Best Quality Pharma
Products
Founder & CEO
Umesh Kalra
India is the 2nd most populated country in the world
and one of the fastest growing economies on Earth. In
coming years with the continued growth, there will be
the population explosion in India. These people will need
good facilities, which include the healthcare sector and
medicines. Thus, the demand for quality and effective
pharma products will be high.
A Pharma business is one of the best ways by which a
company provides its products to several regions of the
country. Pharma is considered as the backbone of the
pharma companies. It works as a bridge between the
pharma company and the customers.
Arlak Biotech is one such leading Pharma Company in
Punjab, India. They offer an extensive variety of
Pharmaceutical products to healthcare industry at the most
affordable cost. Arlak biotech is marketing more than
1000+ brands for different human medical requirements.
Their portfolio incorporate Tablets, Softgel Cap, Capsules,
Injectables, Syrups, Topical gels, Creams, Oils, Lotions,
Drops, Sachet and many more others as per medical
requirements.
To make their products within the scope of all patient
population, Arlak Biotech keeps their value structure to a
moderate level to suits the short and long terms needs of
patients. They follow stringent quality control measures
which affirm to the standards of pharmaceutical and
guarantee full therapeutic values. Arlak Biotech is a WHO-
GMP Certified Pharma Marketing Company and has a vast
distribution network which guarantees convenient access of
their pharmaceutical formulations throughout the country.
The Leading Light
Umesh Kalra, Founder and CEO of Arlak Biotech has a
vision of becoming one of the top international companies
in the healthcare sector. Umesh is a proud pharmacy
graduate who started his career as a medical representative.
With an incredible passion to provide healthcare to the
masses at a reasonable price, Umesh initiated Arlak
Biotech.
Gaining motivational support from friends and family,
32 Mar-Apr 2018/

35. Arlak Biotech not only
makes products that
their customers want
now, but also develop
new and innovative
products for their
customer's future
needs
‘‘
‘‘
Arlak Biotech’s journey started with
3 products. Due to the lack of funds,
Umesh contributed for every job possible and
worked in various sectors such as designing, field work, and
even distribution.
Under the expert guidance of Umesh, in 2015, Arlak
Biotech received Businessmen excellence award “Best
Quality Company in Pharma” from Dr. Harsh Vardhan
(Union Cabinet Minister). And in 2016, the company added
one more feather in its cap when Arlak Biotech received
another award “Pharma Company with Ethical Marketing
Practice” from Sh. Mansukh L Mandaviya, Hon’ble
Minister of Chemical Fertilizer & Pharmaceutical.
Innovative Approaches
At Arlak Biotech, they have a complete and efficient
distribution network throughout the country to guarantee
accessibility of the products at all the locations in India
constantly. They have a strong customer data base and they
do their best to keep them fully satisfied. This has resulted
in and astonishing increasing month after month in the
customer data base.
The company believes in fulfilling the social
responsibilities beyond the business. They are providing the
best quality Pharmaceutical Products to the healthcare
industry with a proficient distribution network which
guarantees accessibility of their entire pharma products
range to reach the valuable customers within 2-4 days. They
have exceptionally imaginative and straightforward
promotional inputs through brilliant showcasing and easily
understandable marketing information.
Distinctive Products and Services
Taking a broader look at the requirements of boundless
patient population, Arlak Biotech’s value structure of whole
products range fits to the clinical requirement of the vast
patient population. Their product portfolio meets effectively
to healthcare management for joint pain, swelling,
cardiovascular disorders, diabetes management,
Gastroenterology, Respiratory Disorders, Nutrition, Diet
Supplements and Skin care and others.
Moreover, the company also has a complete Ayurvedic
product range along with a nutraceuticals and cosmetic
range. Arlak is planning to enter the critical care segment
and have recently launched Men’s grooming range.
Upcoming Endeavors
Arlak biotech aims to become a top leading name in the
healthcare industry while adding more segments where
humanity is facing health related troubles. Arlak biotech is
planning to educate patients about upcoming threats such as
cancer and other deadly disease. In India, the average
lifespan is less compared to other developed countries, and
a lot of work has to be done to provide an effective and
economical healthcare solution to the citizens and Arlak
Biotech aims to do just that.
Mar-Apr 2018 33/

36. Ambati Venu
Managing Director
Abbott India Limited
34 Mar-Apr 2018/

37. Antelligence
Marketing in Healthcare
rtificial
I
Tomorrow’s world of patient care will be different and much more efficient than today. It is no surprise that
Artificial Intelligence marketing strategies will impact, and to a large extent are already impacting, the way we in
the healthcare industry, do business. The use of artificial intelligence in marketing will benefit the researchers,
doctors as well patients – from faster discoveries, faster clinical results, quicker and accurate diagnosis, to a personalized
consumer experience. Artificial intelligence has unimaginable possibilities. How do we tap it?
A recent Capgemini study highlighted the vast implementation of AI solutions by companies from various sectors, and
emphasized that AI has already transformed their traditional way of business, managing customer relationships, and has
helped inspire ideas that fuel innovation. For healthcare, this would mean a revolutionary change in patient care.
We all have used the Google’s AI-powered predictions for location mapping; tapped on Siri/Cortana to ask the latest movie
timings – the world is witnessing rapid change through AI. For healthcare - solutions that can help stakeholders across the
value chain will benefit, and technologies such as AI will help reduce adverse drug reactions, drug-drug interactions, the
time-to-market, improve diagnosis and patient experiences. Amid shrinking pipelines, and the ever-elusive need to reduce
the time to market products, we in the pharma industry are running a race with time. In such a scenario, technologies are a
crucial fulcrum that will propel a quicker, efficient growth.
Near-future AI marketing interventions
With a patient-centric approach, marketers in the healthcare industry are on the lookout to maintain genuine patient
relationships that drive long-term reputation and trustworthiness. Considering this, AI solutions that better treatment
approaches, provide and securely manage copious patient data, backed by affordable and accessible analytics, will open up
possibilities of personalizing consumer experience.
In the near future, AI would bring in changes at several levels, noticeably:
- Personalized healthcare solutions: AI is gradually changing the problem-solving approach for healthcare – be it at the
patient or the caregivers end. With AI-led solutions, it is now possible to identify the crucial interventions in the clinical
journey basis cohort-studies. Medical data is currently being tested to reflect the clinical performances of systems. AI
Entrepreneur’s Outlook
Mar-Apr 2018 35/

38. algorithms are already being tested that optimizes dosage forms in real time according to patient s lifestyle. Along with’
accurate and quicker clinical outcomes, analytics from cohort studies will help to design the elusive “individualized”
healthcare solutions for patients. IBM Watson has been providing support across the continuum of care and will change
the paradigm of clinical decision making with individualized solutions.
- Improving health outcomes: AI and such cognitive technologies will continue to expand in the augmentation of
clinical decision making from reading scans to improving outcomes through better treatment decisions. We have also
seen its application in predicting risk factors, ensuring better compliance, and avoiding adverse reactions. Through a
dedicated Service + Pill ecosystem, we would be able to improve patients’ adherence to treatment and also provide real-
time treatment options for better health outcomes.
Innovations galore…
As a patient-centric pharma company our mission is to help people lead a healthier and fuller life. Innovation is at the
center of most things that we do at Abbott and AI marketing will definitely help us in this journey. Imagine using Google
Assistant or Amazon Alexa for ordering medicine without human intervention? Or having an AI-powered bedside
virtual assistant for patients that can answer their queries?
The future of having customer bots for filtering medical data or renewing prescriptions are not far away. Along with a
smooth customer experience, such solutions will ensure timely refilling of Rx and improve adherence rates in patients.
In areas with a poor access and lacking healthcare systems, AI virtual bots will be able to provide basic healthcare
information and guidance. In a country like India, this will help solve the major issues of timely accessibility and
monitoring of patients in the long run.
While there have been some concerns over how AI may affect human workforce and the security of patient data, we
need to understand that AI augments human interventions. Let’s use it not only to take over complex, time-consuming
tasks, but also to ensure efficiency and for shortening the patient journey from diagnosis to treatment and compliance. AI
solutions must be able to ensure patient data security, only then we will be able to use it to the fullest.
We have some AI-led times ahead!
36 Mar-Apr 2018/

40. Would you Prefer Genetic Perfection?
Engineered Babies:
Envision yourself sitting comfortably in a fertility
clinic, sipping coffee, you pick up the menu and
start choosing. Will you go for tall or short? Would
you prefer blue eyes or brown? Would you fancy clever or
funny? When you are done selecting, head down to the
counter and order yourself a new baby!
With rapid improvements in scientific knowledge of human
genome and our increasing ability to change and modify
genes, this scenario of ‘designing’ your own baby could
very well be possible in the near future. Although the
concept of genetic engineering has always been on the mind
of science fiction writers and biochemists for almost a
decade, only recently has it been in the spotlight. This is
due to the current successful events of gene editing.
Genome editing is biological editing in which DNA is
inserted, deleted or replaced in a living organism using
nucleases or molecular scissors. In the human genome,
genetic information is stored in 23 pairs of chromosomes,
and written only in four alphabets viz., A, T, G, and C. It
carries coded information for all the processes one would
require throughout life. This data is subjected to numerous
factors which can alter the genetic make-up and lead to
disorders. Thus this altered information if carried by either
parent and passed on to the offspring can cause a genetic
disorder. Even if the faulty gene is not expressed in the
offspring, it nevertheless can act as the carrier of that
disease. The only preventive measure for informed parents
with a family history of genetic disorders is to screen the
amniotic fluid for defective genes.
In the last decade, CRISPR/Cas9 technology has been the
primary tool for those seeking to modify genes. It uses
38 Mar-Apr 2018/

41. natural enzymes to target and slice genes with pinpoint accuracy. It has
already been used to genetically modify nonviable embryos in China.
Recently, a team of scientists in Oregon successfully modified the
DNA of a human embryo by repairing a single gene mutation using
CRISPR to cure a fatal heart condition caused by a genetic mutation.
This could, in theory, mean that CRISPR would be able to prevent the
same mutation from affecting any embryo.
Although, the process remains arduous and challenging as there are
numerous genes responsible for one single trait. For example,
something like height is approximately coded by 93,000 genetic
variations. And considering current capabilities, it is next to
impossible to test each of those genes to make any significant
difference. Although it can take very little time to alter a single gene,
altering thousands, and figuring out which ones to alter, is very time-
consuming. The more complicated concept is the use of genetic
editing for repairing genetic disorders like Alzheimer’s, Blindness and
even Cystic Fibrosis. But access to such tools is limited and thus
expensive, resulting in an increase in the economic divide.
The concept of using CRISPR for human reproduction is rejected at
large by the medical research community. Besides, there seems to be
little need for gene editing in human reproduction. It would be
difficult, uncertain and expensive to achieve what can most likely be
gained by other ways, particularly by selecting an embryo that has or
lacks the gene. “Almost everything you can accomplish by gene
editing, you can accomplish by embryo selection,” says bioethicist
Henry Greely of Stanford University.
Moreover, recently when the researchers sliced out the faulty portion
of the gene and tried to replace it with the correct version, the
embryonic cells disregarded it and copied the healthy version from the
other set of chromosome. Essentially, the cells ignored the DNA that
was externally added and favored the DNA that was already present.
This increases the possibility that instilling major changes in the
human genome won’t work because the embryos will reject the
editing. Nonetheless, with the technology coming into existence, many
are worried that “designer babies” will be unavoidable. That, however,
is far from the obvious.
The opinion that genetics, evolution and natural selection should be
left to nature, rather than human intervention, is not a new one.
Meddling in the evolution of human beings can have austere
consequences.
Essential genetic realism and bioethical considerations will prevent
“designer babies” from being prevalent. Nonetheless, we can expect
that improved genetically modified crops and other organisms can be
fashioned using CRISPR. In the near future, that is the most likely use
for genome editing. For now, though, if there is going to be anything
even vaguely similar to the widespread designer-baby fantasy, it will
come from embryo selection, and not from genetic manipulation.
Inside Scoop
Mar-Apr 2018 39/

42. VovantisVovantis
Laboratories:Laboratories:
Vovantis
Laboratories:
Leading the
Pharmaceutical Market
while using Effervescent
Technology
Founder & CEO
Mohal Sarabhai
The uses of effervescent technology have gained
popularity in the market. These tablets or
medicines are designed in such a way that it gets
dissolved in water easily, while regular medicine lacks this
quality. This quality of effervescent medicines has been
proved beneficial for those people who are taking
medicinally and as a diet supplement. Pleasant taste, evenly
distribution of elements, increased liquid intake is few
reasons why ‘Effervescent Medicines’ are popular among
people. Using this as an advantage, Vovantis Laboratories
has evolved as one of the best companies which use the
effervescent technologies to produce effervescent
medicines.
Name Synonymous with Effervescent Products
Envisioned with an objective of becoming a global supplier
of Effervescent range of products, Vovantis Laboratories
had onset in the year 2008. Vovantis started delivering
service with offering basic products like tablets and sachets
of Vitamin C, Aspirin, multi vitamins and acetaminophen,
etc. These effervescent products had gained wide
acceptance and success among common people due to its
better taste compared to the regular products. Their
efficiency in masking taste is one of the reasons why,
Vovantis topped the list midst its competitors. The recent
expansion of Vovantis includes the development of a novel
product that uses curcumin in effervescent form. This
product is currently being tested for its efficiency in cancer
treatment as the essence of curcumin helps in cancer care.
The unique formula used by Vovantis which combines
curcumin with piperazine extract, gives an effervescent
effect which helps it to be absorbed easily by the human
body. Vovantis offers a complete range of service to its
private lable customers that include product development,
analysis in pilot batches, commercial batches and
customized labeling and packaging for strip foils and
cartons, tubes and sachets. The products manufactured by
Vovantis have a global market including in countries like
USA and Canada while the products are being
manufactured in India.
The Man Who Aids From the Front
Mohal Sarabhai, the Founder and the CEO of Vovantis
Laboratories began his entrepreneur career with the
formation of Asence Inc; a company based out in USA with
a business of supplying key pharmaceutical products
sourced from Asia for North American markets. During this
period he noticed a huge gap in the availability and quality
of effervescent products and the available products did not
taste good. Mohal adds saying, “I decided to change that
and with the help of a European investor incorporated
Vovantis in India as a global prescription of Effervescent
40 Mar-Apr 2018/

43. Vovantis
Laboratories-
Global
prescription for
effervescent
technology
‘‘
‘‘
products”. Vovantis
manufacturing facility was
started in India as India offers unique
advantages in both talent and labor. India also
has the most approved USFDA manufacturing locations
outside of the USA and the company was started in the
State of Gujarat which alone is a hub for many leading
pharmaceutical companies.
Reforming the Market
Mohal agrees to the fact that Effervescent technology offers
faster absorption by the human body due to which it has a
faster onset of action that is critical in treating acute
symptoms such as pain. Also as the effervescent medicines
can be swallowed easily and are gentle on the digestive
tract, the demands of effervescent medicines are increasing.
Mohal asserts, “I believe that more and more products
would become available and patients would prefer the
effervescent route of medicine, if available.” Vovantis are
developing several prescription products while also
working with clients to convince and educate them to brand
extend their existing molecules by offering effervescent
products too. This market strategy has helped Vovantis
Laboratories to expand its business and reach the common
masses. Even though Vovantis Laboratories is now
considered as the leader in the field of effervescent
technology, the initial journey was filled with hardships.
Gaining trust among the common people who have been
relying on regular medicines since generations was one of
the biggest challenges faced by Vovantis. However,
Vovantis was able to overcome this challenge by supplying
good quality products that too timely. The first break which
they received was from US where, Vovantis was asked to
deliver five of their products instantly, and by this climbing
the ladder of success. Mohal states, “When we incorporated
this company with a focus on effervescent products,
initially nobody knew us and so getting any meeting (let
alone sales) was extremely difficult. I started carrying
samples of our products with me and before a meeting
would start would drop a multivitamin or Vitamin C into a
glass of water and request my potential customers to just
take a sip.”Most who took this sip ended up buying from
us.
In store for Future
Vovantis Laboratories have planned to double its enhanced
capacity and produce more products by the year 2020.
Being a global supplier of effervescent pharmaceutical
products comes with responsibilities. Different customers
have different needs and hence; Vovantis is always available
for any of the queries regarding the effervescent products.
Mohal had envisioned the success path of the company
since its uprising. He adds saying, “I have great people
who work with me as friends in achieving that direction
with frankness and enthusiasm. I only work with positive
people and value positive energy immensely.” The near
future would see Vovantis’s involvement in areas such as
veterinary, tank and pool cleaning products as well as bath
and shower medicated products.
www.vovantis.com
w w w . v o v a n t i s . c o m
Mar-Apr 2018 41/

44. High Quality accurate test
report by a pathology
Laboratory is extremely
crucial for a clinician to decide the
correct line of treatment for the patient
and ultimately the fate of the patient.
Furthermore its patient’s right to obtain
accurate report for his hard earned
hefty sum paid towards testing.
The most crucial factor which actually
ensures HIGH QUALITY TEST
REPORTS is patient’s specimen or
SAMPLE which is being tested and
unfortunately this factor is MOST
NEGLECTED in most of the
pathology lab set ups in India. Though
the path labs invest heavily on medical
equipments for biological
measurements, they hardly care for pre
Analytical area which is sample
collection area in laymen’s words.
What is Pre-analytical Process?
Ÿ Patient Identification
Ÿ Phlebotomy
42 Mar-Apr 2018/

45. Ÿ Blood Collection
Ÿ Specimen Transport
Ÿ Specimen Processing
Why to focus on pre-analytical?
Ÿ The pre-analytical stage is the most
important and can be critical to
patient wellbeing
Ÿ The analytical stage and post
analytical stages depend primarily
on the Quality and Integrity of the
specimen submitted to the laboratory
(Pre-Analytical)
Ÿ Laboratory staff involved in
specimen collection has a direct
impact on the outcome of patient’s
lab results
Ÿ Errors made in the period prior to
sample analysis may influence the
final test result.
Ÿ Approximately 32 - 75% of all test
errors occur in the pre-analytical
phase
Possible errors in Pre-analytical
Process
Ÿ Wrong patient ID on the sample
Ÿ Missing patient ID on the sample
Ÿ Wrong collection time
Ÿ Inadequate/ inappropriate container
Ÿ Inadequate volume, inappropriate
volume to anticoagulant ratio
Ÿ Contaminated from IV line
Phlebotomy
Ÿ Phlebotomy is a highly complex
skill requiring expert knowledge and
critical judgment
Ÿ Phlebotomy errors may cause harm
to patients or result in needle stick
injury to the phlebotomist
Ÿ Pediatric and Adult Collections
should be carefully done considering
Size differentiation, Angle of
penetration, Rigidity of vein,
Reliable vein development versus
development of muscle, tendon and
subcutaneous tissue and Psychology
of patient
Suggested solutions to avoid Pre-
analytical Errors
Ÿ Every lab should have Standard
operating procedures for specimen
acceptance /rejection to be followed
by all staff
Ÿ There has to be a manual for
Identification and monitoring of
reasons for specimen rejection
Ÿ Effect of improvement initiative in
decreasing the
rate of
specimen
rejection should be
monitored
Ÿ Path labs should be very
careful in selecting blood
collections tubes and quality
should be the foremost criteria
instead of price. The Blood
collection tubes should be
thoroughly checked for quality
standards before putting them for
collection use.
Most importantly, Path labs need to
accept the effects of Pre-analytical
Variables and believe that there is
indeed room for Improvement.
Also, path labs need to accept the fact
that most errors affecting laboratory
test results occur in the pre-analytical
phase primarily because of the
difficulty in achieving standardized
procedures for sample collection and
selection of high quality blood
collection tube is vital for high quality
test results.
Remember… Concern for the change is
the most important step towards
change.
Pankaj Dhole
Director
Bioteknika Technologies Pvt Ltd
Ahmedabad
CXO Insights
Mar-Apr 2018 43/

48. QUALITYHEALTHCARE
AFFORDABLE PLANS
w w w . f h c p . c o m